The Enterprise Value as of December 2024 (TTM) for Coherus BioSciences, Inc. (CHRS) is 297.54M

According to Coherus BioSciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 297.54M. This represents a change of -34.57% compared to the average of 454.73M of the last 4 quarters.

Coherus BioSciences, Inc. (CHRS) Historical Enterprise Value (quarterly & annually)

How has CHRS Enterprise Value performed in the past?

The mean historical Enterprise Value of Coherus BioSciences, Inc. over the last ten years is 816.20M. The current 297.54M Enterprise Value has changed 3.55% with respect to the historical average. Over the past ten years (40 quarters), CHRS's Enterprise Value was at its highest in in the June 2019 quarter at 1.64B. The Enterprise Value was at its lowest in in the December 2014 quarter at 173.43M.

Coherus BioSciences, Inc. (CHRS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Coherus BioSciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Coherus BioSciences, Inc. (CHRS) Average Enterprise Value

How has CHRS Enterprise Value performed in the past?

The current Enterprise Value of Coherus BioSciences, Inc. (CHRS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Coherus BioSciences, Inc. (CHRS) Enterprise Value vs. Peers

How is CHRS’s Enterprise Value compared to its peers?

Coherus BioSciences, Inc.’s Enterprise Value is greater than Assembly Biosciences, Inc. (68.91M), greater than Spero Therapeutics, Inc. (-19875710.00), greater than Achilles Therapeutics plc (-42108751.00), greater than Instil Bio, Inc. (216.93M), greater than Neoleukin Therapeutics, Inc. (-6333315.00), greater than NextCure, Inc. (3.79M), less than Nuvation Bio Inc. (868.01M), greater than CytomX Therapeutics, Inc. (54.93M), greater than Bolt Biotherapeutics, Inc. (27.76M), less than Gracell Biotechnologies Inc. (5.66B),

Build a custom stock screener for Coherus BioSciences, Inc. (CHRS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Coherus BioSciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Coherus BioSciences, Inc. (CHRS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Coherus BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.